Home › Trial NCT03954691
Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies
- Trial IDNCT03954691
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorNeuromed IRCCS
- Enrollment50
- Start date2019-10-01
- ConditionsCancer of Head and Neck
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.